Texas Gov. Greg Abbott tests negative for COVID-19 four days after positive test

Translate to Spanish or other 102 languages!

Gov. Greg Abbott said he tested negative for COVID-19 on Saturday, four days after a positive diagnosis. Photo Credit:  Sophie Park/The Texas Tribune
Gov. Greg Abbott said he tested negative for COVID-19 on Saturday, four days after a positive diagnosis. Photo Credit:  Sophie Park/The Texas Tribune
 

The Texas Tribune

- Advertisement -

BY KATE MCGEE / THE TEAXS TRIBUNE

Texas Gov. Greg Abbott says he has now tested negative for COVID-19, four days after testing positive for the virus.

“I am told that my infection was brief and mild because of the vaccination I received,” Abbott said in a video he posted on Twitter Saturday afternoon. “So, I encourage others who have not yet received the vaccination to consider getting one.”

- Advertisement -

Abbott said he will continue to quarantine as recommended by doctors and that the first lady, Cecilia Abbott, continues to test negative.

Abbott contracted the virus as the pandemic surges across Texas, with new cases and hospitalizations increasing to levels not seen since the wave in the winter, and the state nearing its previous pandemic peak.

The governor received Regeneron’s monoclonal antibody treatment after testing positive. He said in the video statement he would continue working to open additional antibody therapy centers across the state. Texas recently opened nine antibody infusion centers statewide in an effort to reserve hospital capacity for the most serious cases and prevent hospitalizations. 

Regeneron antibodies are recommended to treat “mild to moderate COVID-19” for people 12 years and older who have tested positive and “are at high risk for progressing to severe COVID-19.”

- Advertisement -

When Abbott announced he tested positive, he said he was not experiencing any symptoms. He did not say whether he experienced any symptoms throughout the past four days.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS McAllen Launches Naming Contest for Advanced Surgical Robot

Using advanced robotic technology to assist surgeons in performing complex procedures with enhanced precision, dexterity and control, robotic surgery represents one of the most significant advancements in modern medicine.

DHR Health Raises Over $520K at 20th “Fishing for Hope” Event

DHR Health made a big splash at the 20th Annual “Fishing for Hope” Tournament, held on August 22 at Jim’s Pier in South Padre Island, raising an impressive grand total of $524,130.

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

The U.S. Food and Drug Administration approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic cancer months ahead of schedule. 

STHS Behavioral Marks Suicide Prevention Month with Community Chalk Event

Every 11 minutes, someone in the United States dies by suicide, according to the Centers for Disease Control and Prevention (CDC), making it one of the nation's leading causes of death.
- Advertisement -